#WarningLetters
FDA Warning Letters: The TRUE Cost of Non-Compliance for Supplement Brands #FDACompliance #SupplementIndustry #WarningLetters
October 31, 2026 at 3:27 AM
The #US #FDA issued similar #warningletters to five different online #peptide vendors on 24th August, giving the companies 15 days to respond to accusations of selling #unapprovednewdrugs.

pharmaphorum.com/news/fda-iss...
FDA issues warning letters to five unapproved GLP-1 websites
In a handful of strongly-worded warning letters, the FDA is cracking down on sales of unapproved peptides - even if they're labelled for research.
pharmaphorum.com
September 3, 2026 at 9:24 AM
Bloomberg - Are you a robot?
www.bloomberg.com
November 24, 2024 at 9:20 PM
Musk's Neuralink should have already had several #WarningLetters from FDA over Neuralink False Safety & Advertising claims.
February 18, 2025 at 2:22 AM
In a move that will delight #NovoNordisk and #EliLilly, the #FDA has sent #warningletters to 30 #telehealth companies, accusing them of #illegallymarketing #compounded #GLP1 agonist formulations.

buff.ly/GbfCB89
March 4, 2026 at 12:00 PM
What can recent FDA Warning Letters teach us?

From recurring GCP failures to sponsor oversight gaps—2024–2025 enforcement actions reveal clear risks.

We break down the patterns and share proactive strategies to stay inspection-ready.
compliancearchitects.com/re...

#WarningLetters #ClinicalTrials
December 2, 2025 at 1:10 PM
What can recent FDA Warning Letters teach us?

From recurring GCP failures to sponsor oversight gaps—2024–2025 enforcement actions reveal clear risks.

We break down the patterns and share proactive strategies to stay inspection-ready.
compliancearchitects.com/re...

#WarningLetters #ClinicalTrials
October 14, 2025 at 12:05 PM
What can recent FDA Warning Letters teach us?

From recurring GCP failures to sponsor oversight gaps—2024–2025 enforcement actions reveal clear risks.

We break down the patterns and share proactive strategies to stay inspection-ready.
compliancearchitects.com/re...

#WarningLetters #ClinicalTrials
September 2, 2025 at 12:05 PM
What can recent FDA Warning Letters teach us?

From recurring GCP failures to sponsor oversight gaps—2024–2025 enforcement actions reveal clear risks.

We break down the patterns and share proactive strategies to stay inspection-ready.
compliancearchitects.com/re...

#WarningLetters #ClinicalTrials
June 16, 2025 at 12:15 PM
Habe es ja schon mal gesagt: JFK wird die FDA bis zur funktionsunfähigkeit zusammen schießen und dann wird es richtig lustig in der Branche.
Wenn ich mir alleine angucke was die in den letzten 8 Wochen an warningletters rausgehauen haben. Gute Nacht wenn das wegfällt Dann will ich keine Arznei mehr
December 13, 2024 at 4:34 PM